共 136 条
[1]
Magill SS(2014)Multistate point-prevalence survey of health care-associated infections N Engl J Med 370 1198-1208
[2]
Edwards JR(2015)Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes Int J Infect Dis 37 129-134
[3]
Bamberg W(2003)The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit Clin Microbiol Infect 9 412-418
[4]
Sligl WI(1983)Cefoperazone: a review of its antimicrobial spectrum, b-lactamase stability, enzyme inhibition and other in vitro characteristics Rev Infect Dis 5 108-126
[5]
Dragan T(1988)Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0g) coadministered to subjects with normal renal function patients with decreased renal function, and patients with end-stage renal disease on hemodialysis Antimicrob Agents Chemother 32 503-509
[6]
Smith SW(2006)Extending the life of β-lactam antibiotics: new β-lactamase inhibitors Drug Dis Today: Therapeut Strat 3 183-188
[7]
Zaragoza R(2001)Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains J Antimicrob Chemother 47 479-482
[8]
Artero A(2014)Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis Clin Microbiol Infect 20 416-423
[9]
Camarena JJ(2015)Renal replacement therapy in acute kidney injury: controversy and consensus Crit Care 19 146-271
[10]
Sancho S(2006)Pharmacokinetic changes in critical illness Crit Care Clin 22 255-1193